The researchers emphasized that promoter methylation of the RASSF1A, DAPK1, and p16INK4a MSP panel may be a potentially useful method in detecting hypermethylation events non-invasively in patients with HNSCC. The gene discussed is CDKN2A; the disease is head and neck squamous cell carcinoma.